EUVIMEDEUVIMED entdecken
Crossref

Clostebol Metabolism by Different Routes of Administration: Selection of Diagnostic Urinary Markers

Xavier de la Torre iD, Cristiana Colamonici, Dayamin Martínez Brito iD, Rodny Montes de Oca Porto iD, Francesco Botrè iD

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Xavier de la Torre und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio Antidoping FMSI, Federazione Medico Sportiva Italiana, Rome, Italy. Hauptthemen laut MEDLINE: Anabolic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: World Antidoping Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accidental contamination by the use of transdermal applications of clostebol acetate has been proven by the monitoring of its main urinary metabolite 4‐chloro‐3α‐hydroxy‐androst‐4‐en‐17‐one (M1). This work is aimed at describing clostebol metabolism in humans and at searching for specific metabolic markers or concentration thresholds allowing for distinguishing between an oral and a transdermal administration, helping to set up adequate criteria to be adopted by the antidoping community when incidental contamination is suspected. Urine samples were collected after the administration of a single dose of clostebol acetate orally ( n = 3, males), a single transdermal dose ( n = 1, male), and multiple transdermal administrations ( n = 3, males, and n = 3, females). After enzymatic hydrolysis, liquid–liquid extraction, and the formation of trimethylsilyl derivatives, the samples were analyzed by gas chromatography coupled to tandem mass spectrometry and time‐of‐flight mass spectrometry. The metabolism of clostebol after oral and transdermal applications was described. Ten metabolites were detected after oral administration (M1–M10), but only five (M1–M4 and M9) could be detected after transdermal applications under the assay conditions applied. The use of concentrations of any metabolite might be difficult because of the interindividual variability in absorption, metabolism, and/or excretion. Instead, the ratios between M4 and M1 showed plausible results to discriminate between both administrations under the conditions described here. The intentionality of the use of one or other route of administration cannot be assessed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anabolic AgentsHumansMaleFemaleGas Chromatography-Mass SpectrometryTandem Mass SpectrometryAdministration, OralAdministration, CutaneousBiomarkersSubstance Abuse DetectionAdultDoping in SportsLiquid-Liquid Extraction

Stichwörter der Autor:innen

GC‐MS/MSadministration routeclostebolmetabolic ratiosmetabolism

Substanzen

BiomarkersAnabolic Agents

Autor:innen und Institutionen

  • Laboratorio Antidoping FMSI, Federazione Medico Sportiva Italiana, Rome, Italy.
  • Laboratorio Antidoping of Havana, Ministry of Public Health, La Habana, Cuba.

ORCID-Profile: Xavier de la Torre, Dayamin Martínez Brito, Rodny Montes de Oca Porto, Francesco Botrè

Förderung

  • World Antidoping Agency

Zitieren

APA

de la Torre, X., Colamonici, C., Martínez Brito, D., de Oca Porto, R. M., & Botrè, F. (2025). Clostebol Metabolism by Different Routes of Administration: Selection of Diagnostic Urinary Markers. Drug Testing and Analysis. https://doi.org/10.1002/dta.3953

Vancouver

de la Torre X, Colamonici C, Martínez Brito D, de Oca Porto RM, Botrè F. Clostebol Metabolism by Different Routes of Administration: Selection of Diagnostic Urinary Markers. Drug Testing and Analysis. 2025. doi:10.1002/dta.3953

BibTeX
@article{delaTorre2025,
  author = {de la Torre, Xavier and Colamonici, Cristiana and Martínez Brito, Dayamin and de Oca Porto, Rodny Montes and Botrè, Francesco},
  title = {Clostebol Metabolism by Different Routes of Administration: Selection of Diagnostic Urinary Markers},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3953}
}
Kostenlos starten →